Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 134
Overview
Dr. Lee M. Ellis
UT M. D. Anderson Cancer Center, Houston, TX
from 2005 Molecular Targets and Cancer Therapeutics conference on November 15, 2005 10:30 AM-12:30 PM
Semaphorins and Neuropilins Are Regulators of Tumor Angiogenesis
Dr. Michael Klagsbrun
Children's Hospital, Boston, MA
from 2005 Molecular Targets and Cancer Therapeutics conference on November 15, 2005 10:30 AM-12:30 PM
Notch Signaling in Angiogenesis and Melanoma Progression
Dr. Meenhard Herlyn
The Wistar Institute, Philadelphia, PA
from 2005 Molecular Targets and Cancer Therapeutics conference on November 15, 2005 10:30 AM-12:30 PM
Suppression of Angiogenesis and Tumor Growth by Selective Inhibition of Angiopoietin-2
Dr. Jonathan D. Oliner
Amgen, Thousand Oaks, CA
from 2005 Molecular Targets and Cancer Therapeutics conference on November 15, 2005 10:30 AM-12:30 PM
Integrin alpha-4 beta-1 as a Novel Tumor Molecular Target
Dr. Judith A. Varner
Moores UCSD Cancer Center, La Jolla, CA
from 2005 Molecular Targets and Cancer Therapeutics conference on November 15, 2005 10:30 AM-12:30 PM
Identifying Molecular Targets for Cancer Prevention: Overview
Dr. Eva Szabo
National Cancer Institute, Bethesda, MD
from 2005 Molecular Targets and Cancer Therapeutics conference on November 15, 2005 2:30 PM-4:30 PM
Aromatase and ER as Targets for Prevention in Breast Cancer
Dr. Mitchell Dowsett
Royal Marsden Hospital, London, England
from 2005 Molecular Targets and Cancer Therapeutics conference on November 15, 2005 2:30 PM-4:30 PM
Overview
Dr. Sanjiv Sam Gambhir
Stanford University, Stanford, CA
from 2005 Molecular Targets and Cancer Therapeutics conference on November 16, 2005 8:00 AM-10:00 AM
Imaging and Targeted Therapy: Using PET in Clinical Trials and Clinical Practice
Dr. David A. Mankoff
University of Washington, Seattle, WA
from 2005 Molecular Targets and Cancer Therapeutics conference on November 16, 2005 8:00 AM-10:00 AM
Functional Molecular Imaging to Predict and Monitor Response to Targeted Therapy
Dr. Robert J. Gillies
Arizona Cancer Center, Tucson, AZ
from 2005 Molecular Targets and Cancer Therapeutics conference on November 16, 2005 8:00 AM-10:00 AM
Update on HER2 Directed Therapy
Dr. Dennis J. Slamon
UCLA School of Medicine, Los Angeles, CA
from 2005 Molecular Targets and Cancer Therapeutics conference on November 16, 2005 10:30 AM-12:30 PM
Update on the Epidermal Growth Factor Receptor Targeting
Dr. José Baselga
Vall d'Hebron University Hospital, Barcelona, Spain
from 2005 Molecular Targets and Cancer Therapeutics conference on November 16, 2005 10:30 AM-12:30 PM
Disrupting IGF Receptor Signaling as a Cancer Therapy
Dr. Douglas Yee
University of Minnesota, Minneapolis, MN
from 2005 Molecular Targets and Cancer Therapeutics conference on November 16, 2005 10:30 AM-12:30 PM
Tumor-Specific Nanodelivery Systems: Expanding the Potential for Cancer Therapy and Diagnosis
Dr. Esther Chang
Georgetown University, Washington, DC
from 2005 Molecular Targets and Cancer Therapeutics conference on November 16, 2005 2:30 PM-4:30 PM
Targeted Nanoparticle Beacons for Quantification of Molecular Epitopes and Drug Delivery
Dr. Samuel A. Wickline
Washington University, St. Louis, MO
from 2005 Molecular Targets and Cancer Therapeutics conference on November 16, 2005 2:30 PM-4:30 PM
Apoptosis-based Therapies for Cancer
Dr. John C. Reed
The Burnham Institute, La Jolla, CA
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 8:00 AM-10:00 AM
Human Recombinant TRAIL/Apo2L and Agonistic Monoclonal Antibodies to TRAIL Death Receptors from the Laboratory to the Clinic
Dr. E. G. Elisabeth de Vries
University Hospital, Groningen, The Netherlands
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 8:00 AM-10:00 AM
Developing Chemotherapeutics that Target Mitochondria
Dr. Craig B. Thompson
University of Pennsylvania, Philadelphia, PA
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 8:00 AM-10:00 AM
The IAP Proteins and the XAF1 Antagonist as Cancer Targets
Dr. Robert Korneluk
University of Ottawa, Ottawa, ON, Canada
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 8:00 AM-10:00 AM
TRAIL Receptor Targeted Therapy
Dr. Donald J. Buchsbaum
University of Alabama, Birmingham, AL
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 10:30 AM-12:30 PM
Recombinant Antibody-based Therapeutics
Dr. Richard H. J. Begent
University College London, London, England
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 10:30 AM-12:30 PM
Development and Regulation of New Drugs in Targeted Subgroups
Dr. Jaap Verweij
Erasmus University Medical Center, Rotterdam, The Netherlands
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 2:30 PM-4:30 PM
The Revised European Guidelines for Anticancer Drug Development
Dr. Patrick Therasse
EORTC Data Center, Brussels, Belgium
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 2:30 PM-4:30 PM
Recent Guidance on Early Drug Development
Dr. Jerry M. Collins
Food & Drug Administration, Rockville, MD
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 2:30 PM-4:30 PM
Report on Workshops Dedicated to Endpoints in Cancer Clinical Trials
Dr. Ramzi N. Dagher
Food & Drug Administration, Rockville, MD
from 2005 Molecular Targets and Cancer Therapeutics conference on November 17, 2005 2:30 PM-4:30 PM
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 134